Technology and services at the frontline of healthcare
GE’s Healthcare business has been active for over four decades in the Middle East, partnering with some of the region’s leading providers to bring its portfolio of technologies and health solutions to the region.
GE is addressing the healthcare challenges unique to the region by implementing integrated strategies that support clinicians in diagnosing disease and improving patient outcomes and overall healthcare delivery.
In the UAE, home to our regional headquarters, GE Healthcare has partnered with key public and private providers including City Hospital, the Dubai Health Authority, MAF Ventures and Saha Abu Dhabi.
Capitalizing on the UAE’s deep domain expertise in logistics, last year GE Healthcare, in partnership with Ceva, inaugurated its first distribution warehouse center in the Jebel Ali Free Trade Zone Area. The 30,000 square foot facility is the first for GE Healthcare serving Europe, the Middle East, Africa, Russia, Turkey and Central Asia.
Now, even brighter possibilities are coming to light with new quantitative tools that generate more consistent PET measurements. With GE’s Q.Clear PET/CT solution, clinicians can more accurately assess treatment response for cancer patients. Q.Clear technology provides up to two times improvement in PET quantitative accuracy and image quality, enabling clinicians to quickly and confidently evaluate a patient’s response to cancer treatment.
SenoClaire’s three-dimensional imaging technology and low-dose X-ray sweep enhances imagery of masses and lesions. The enhanced resolution help radiologists reduce recall rates and identify earlier.
GE Healthcare’s breakthrough ultra-fast CT scanner, 510(k)-pending, Revolution CT, captures motion-free images of the human heart and other organs. Enabling clinicians to non-invasively visualize the human heart will improve the treatment of patients with erratic or high heartbeats.
Cancer is the third leading cause of death in the UAE, after cardiovascular disease and accidents. Limited oncology services often force Dubai residents to travel abroad for treatment. To reverse this trend, Mediclinic City Hospital plans to expand its facility to include an advanced oncology unit at Dubai Healthcare City (DHCC) by the third quarter of 2015. This project will increase the Emirate’s cancer care capacity and provide the latest diagnostic technology.
DHCC and GE Healthcare signed a Memorandum of Understanding (MoU) to support human capital development in the region’s healthcare sector. As part of the MoU, GE will participate in the delivery of world-class healthcare training and education programs at the Mohammed Bin Rashid Academic Medical Center (MBR-AMC) for healthcare professionals, in addition to introducing leadership curriculums from GE’s world-renowned Crotonville leadership center.